{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-081547","form_type":"8-K","ticker":"RFL","cik":"0001713863","company_name":"Rafael Holdings, Inc.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.152314+00:00","generated_at":"2026-06-09T06:05:54.380127+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rafael Holdings reports Q4 net income of $1.3M; full-year loss narrows to $8.7M","bullets":["Q4 net income from continuing ops $1.3M ($0.06/share) vs loss of $4.6M ($0.24/share) a year ago.","Full-year FY2023 net loss from continuing ops $8.7M ($0.36/share) vs $140.5M ($6.22/share) prior year which included large write-offs.","Cash, cash equivalents and marketable securities of $79.2M as of July 31, 2023.","Suspended Barer Institute activities; sold real estate for $33M net proceeds; invested in Cyclo Therapeutics (CYTH) and Day Three Labs.","R&D expenses reduced to $1.3M in Q4 from $1.8M; G&A down to $1.4M from $3.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-081547","json":"https://secwatch.observer/filing/0001213900-23-081547.json","markdown":"https://secwatch.observer/filing/0001213900-23-081547.md","text":"https://secwatch.observer/filing/0001213900-23-081547.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023081547/0001213900-23-081547-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023081547/ea187457-8k_rafael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:05:54.380127+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"064a964ce825b6e4cb61417ff2bf5cb69d1c51d4","claim":"Rafael Holdings, Inc. reported the twelve months ended July 31, 2023 results: net income a net loss from continuing operations of $8.7 million, or $0.36 per share, EPS $0.36 per share.","evidence_excerpt":"For the twelve months ended July 31, 2023, we incurred a net loss from continuing operations of $8.7 million, or $0.36 per share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023081547/0001213900-23-081547-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the twelve months ended July 31, 2023"},{"label":"Net income","value":"a net loss from continuing operations of $8.7 million, or $0.36 per share"},{"label":"EPS","value":"$0.36 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"af81c7e0f066f929dfcc74aa04a33efa3b7fb05f","claim":"Rafael Holdings, Inc. reported the three months ended July 31, 2023 results: net income $1.3 million, or $0.06 per share, EPS $0.06 per share.","evidence_excerpt":"For the three months ended July 31, 2023, we incurred net income from continuing operations of $1.3 million, or $0.06 per share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023081547/0001213900-23-081547-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended July 31, 2023"},{"label":"Net income","value":"$1.3 million, or $0.06 per share"},{"label":"EPS","value":"$0.06 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}